Announced
Synopsis
Pfizer, an American multinational pharmaceutical and biotechnology corporation, agreed to acquire manufacturing facility in Sanford of Abzena, a provider of services and technologies for the selection, development, and manufacture of biopharmaceutical products. Financial terms were not disclosed. “We’re thrilled to announce this agreement with Pfizer. I am very proud of the facility and our colleagues who worked tirelessly in its construction, and we look forward to building our future collaboration with Pfizer,” Matt Stober, Abzena CEO.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.